A new study out of Australia finds suicide prevention organizations and key opinion leaders with ties to pharma ignored key findings & minimized the importance of FDA warnings about suicidality as an adverse effect of drugs marketed as antidepressants.

As more teens are prescribed SSRIs off label, the risk of iatrogenic harms precipitated by akathisia also likely increases. Get the full story at https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00478/full?fbclid=IwAR0tRGKGFAxUrjveP3OV_PIt9R6eMYMqWKvX3XOx19kzPPthHVFmBBsQErc